HTR1B and migraine disorder: On the other hand, traditional migraine medication therapy, including triptans, ergotamines, acetaminophen, and non-steroidal anti-inflammatory drugs, aims to block 5HT-1B and 5HT-1D receptors or prevent inflammatory substances from producing via the COX pathway, which often lead to adverse effects due to systemic action of these pathways.